PV pharm branch, vendor, cage 0U9U0

Ended Awarded Last action

Contract number
SPE2D826F04T5
Awardee
Awarding agency
Obligated
$193,440

Award facts

Contract value 100% obligated
$193,440.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325411 Medicinal and Botanical Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Conshohocken, PA 19428, USA

Award details come from SAM.gov/FPDS.

About this award

AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a Delivery Order contract award (Contract No. 4570123151) from the Defense Logistics Agency's Medical Supply Chain on December 1, 2025, with an ultimate completion date of December 2, 2025. This firm fixed-price delivery order, valued at $193,440, represents a child contract under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999 and extends through December 2026. The award was made through open competition with no set-aside designation. Under this delivery order and its parent IDC, AmerisourceBergen supplies a comprehensive range of pharmaceutical products and medical supplies to support federal military and healthcare systems, including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains.

This contract demonstrates AmerisourceBergen's established role as a critical pharmaceutical vendor for the Department of Defense. The company's federal contract portfolio reflects consistent competitively awarded delivery orders with firm fixed pricing, ranging from small transactions to substantial orders exceeding $45,000. Through the DLA Troop Support Medical IDC, AmerisourceBergen serves multiple federal healthcare customers, including the Defense Health Agency and U.S. Coast Guard, providing pharmaceutical support on a global scale. The Defense Logistics Agency's planned Pharmaceutical Prime Vendor Global Program Generation V initiative indicates the strategic importance of AmerisourceBergen's role in maintaining pharmaceutical supply chains for military healthcare operations.

Quick answers

Who was awarded contract SPE2D826F04T5?

SPE2D826F04T5 was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on December 1, 2025.

How much is contract SPE2D826F04T5 worth?

The government has obligated $193,440 on SPE2D826F04T5.

Is contract SPE2D826F04T5 an order under another contract?

Yes. SPE2D826F04T5 is a delivery order under SPE2DX22D0069, an indefinite delivery contract.

Was contract SPE2D826F04T5 competed?

The extent of competition for SPE2D826F04T5 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award